AAAAAA
Results: 1-25/44
Authors:
BROXMEYER HE
ORAZI A
HAGUE NL
SLEDGE GW
RASMUSSEN H
GORDON MS
Citation: He. Broxmeyer et al., MYELOID PROGENITOR-CELL PROLIFERATION AND MOBILIZATION EFFECTS OF BB10010, A GENETICALLY-ENGINEERED VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA, IN A PHASE-I CLINICAL-TRIAL IN PATIENTS WITH RELAPSED REFRACTORY BREAST-CANCER/, Blood cells, molecules, & diseases, 24(2), 1998, pp. 14-30
Authors:
FALKSON G
GELMAN RS
PANDYA KJ
OSBORNE CK
TORMEY D
CUMMINGS FJ
SLEDGE GW
ABELOFF MD
Citation: G. Falkson et al., EASTERN-COOPERATIVE-ONCOLOGY-GROUP RANDOMIZED TRIALS OF OBSERVATION VERSUS MAINTENANCE THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER IN COMPLETE REMISSION FOLLOWING INDUCTION TREATMENT, Journal of clinical oncology, 16(5), 1998, pp. 1669-1676
Authors:
FIFE RS
SLEDGE GW
ROTH BJ
PROCTOR C
Citation: Rs. Fife et al., EFFECTS OF DOXYCYCLINE ON HUMAN PROSTATE-CANCER CELLS IN-VITRO, Cancer letters, 127(1-2), 1998, pp. 37-41
Authors:
BLOUGH RI
VANCE GH
HENEGARIU O
SMOLAREK TA
SLEDGE GW
HEEREMA NA
Citation: Ri. Blough et al., CHARACTERIZATION OF MULTIPLE 12P REARRANGEMENTS IN TESTICULAR GERM-CELL TUMOR-CELL LINE 833K AND ITS SUBCLONE 64CP BY CHROMOSOME MICRODISSECTION, Cancer genetics and cytogenetics, 106(1), 1998, pp. 24-29
Authors:
SPARANO JA
NEUBERG D
GLICK JH
ROBERT NJ
GOLDSTEIN LJ
SLEDGE GW
WOOD W
Citation: Ja. Sparano et al., PHASE-II TRIAL OF BIWEEKLY PACLITAXEL AND CISPLATIN IN ADVANCED BREAST-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(5), 1997, pp. 1880-1884
Authors:
FIFE RS
SLEDGE GW
PROCTOR C
Citation: Rs. Fife et al., EFFECTS OF VITAMIN-D-3 ON PROLIFERATION OF CANCER-CELLS IN-VITRO, Cancer letters, 120(1), 1997, pp. 65-69
Authors:
NAKSHATRI H
BHATNAKSHATRI P
MARTIN DA
GOULET RJ
SLEDGE GW
Citation: H. Nakshatri et al., CONSTITUTIVE ACTIVATION OF NF-KAPPA-B DURING PROGRESSION OF BREAST-CANCER TO HORMONE-INDEPENDENT GROWTH, Molecular and cellular biology, 17(7), 1997, pp. 3629-3639
Authors:
FIFE RS
ROUGRAFF BT
PROCTOR C
SLEDGE GW
Citation: Rs. Fife et al., INHIBITION OF PROLIFERATION AND INDUCTION OF APOPTOSIS BY DOXYCYCLINEIN CULTURED HUMAN OSTEOSARCOMA CELLS, The Journal of laboratory and clinical medicine, 130(5), 1997, pp. 530-534
Authors:
FIFE RS
SLEDGE GW
PROCTOR C
Citation: Rs. Fife et al., INHIBITION BY VITAMIN-D-3 OF CELL-PROLIFERATION IN SEVERAL CANCER CELL-LINES, Journal of investigative medicine, 44(7), 1996, pp. 372-372
Authors:
FIFE RS
SLEDGE GW
PROCTOR C
DUNN J
Citation: Rs. Fife et al., DOXYCYCLINE INHIBITS MATRIX METALLOPROTEINASE ACTIVITY AND ENHANCES APOPTOSIS IN HUMAN PROSTATE-CANCER CELLS, Journal of investigative medicine, 44(3), 1996, pp. 249-249
Authors:
FISCH MJ
HOWARD KL
EINHORN LH
SLEDGE GW
Citation: Mj. Fisch et al., RELATIONSHIP BETWEEN PLATINUM-DNA ADDUCTS IN LEUKOCYTES OF PATIENTS WITH ADVANCED GERM-CELL CANCER AND SURVIVAL, Clinical cancer research, 2(6), 1996, pp. 1063-1066
SHOULD WE DREAM THE IMPOSSIBLE DREAM - THE MEANING OF LONG-TERM SURVIVAL IN METASTATIC BREAST-CANCER
Authors:
SLEDGE GW
Citation: Gw. Sledge, SHOULD WE DREAM THE IMPOSSIBLE DREAM - THE MEANING OF LONG-TERM SURVIVAL IN METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2191-2193
Authors:
GORDON MS
MCCASKILLSTEVENS WJ
BROXMEYER HE
BATTIATO LA
HARRISONMANN B
KOVALSKY M
RASMUSSEN HS
SLEDGE GW
Citation: Ms. Gordon et al., A PHASE-I TRIAL OF SUBCUTANEOUS (SC) BB-10010 IN BREAST-CANCER PATIENTS (PTS) RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE, Experimental hematology, 24(9), 1996, pp. 434-434
Authors:
ORAZI A
COOPER RJ
TONG J
GORDON MS
BATTIATO L
SLEDGE GW
KAYE JA
KAHSAI M
HOFFMAN R
Citation: A. Orazi et al., EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) ON MEGAKARYOCYTOPOIESIS IN HUMAN BONE-MARROW, Experimental hematology, 24(11), 1996, pp. 1289-1297
Authors:
SLEDGE GW
Citation: Gw. Sledge, PACLITAXEL DOUBLETS IN METASTATIC BREAST-CANCER - EASTERN-COOPERATIVE-ONCOLOGY-GROUP AND HOOSIER-ONCOLOGY-GROUP STUDIES, Seminars in oncology, 23(5), 1996, pp. 57-59
Authors:
SLEDGE GW
Citation: Gw. Sledge, ADJUVANT THERAPY FOR EARLY-STAGE BREAST-CANCER, Seminars in oncology, 23(1), 1996, pp. 51-54
Authors:
SLEDGE GW
Citation: Gw. Sledge, IMPLICATIONS OF THE NEW BIOLOGY FOR THERAPY IN BREAST-CANCER, Seminars in oncology, 23(1), 1996, pp. 76-81
Authors:
SLEDGE GW
Citation: Gw. Sledge, ROLE OF PACLITAXEL IN THE TREATMENT OF BREAST-CANCER - THE AMERICAN COOPERATIVE GROUP EXPERIENCE, Seminars in oncology, 23(1), 1996, pp. 10-12
Authors:
GORDON MS
MCCASKILLSTEVENS WJ
BATTIATO LA
LOEWY J
LOESCH D
BREEDEN E
HOFFMAN R
BEACH KJ
KUCA B
KAYE J
SLEDGE GW
Citation: Ms. Gordon et al., PHASE-I TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA RHIL-11 GROWTH-FACTOR) IN WOMEN WITH BREAST-CANCER RECEIVING CHEMOTHERAPY, Blood, 87(9), 1996, pp. 3615-3624
Authors:
SLEDGE GW
QULALI M
GOULET R
BONE EA
FIFE R
Citation: Gw. Sledge et al., EFFECT OF MATRIX METALLOPROTEINASE INHIBITOR BATIMASTAT ON BREAST-CANCER REGROWTH AND METASTASIS IN ATHYMIC MICE, Journal of the National Cancer Institute, 87(20), 1995, pp. 1546-1550
Authors:
BROUN ER
SRIDHARA R
SLEDGE GW
LOESCH D
KNEEBONE PH
HANNA M
HROMAS R
CORNETTA K
EINHORN LH
Citation: Er. Broun et al., TANDEM AUTOTRANSPLANTATION FOR THE TREATMENT OF METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(8), 1995, pp. 2050-2055
Authors:
SLEDGE GW
Citation: Gw. Sledge, DOXORUBICIN PACLITAXEL COMBINATION CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP EXPERIENCE/, Seminars in oncology, 22(5), 1995, pp. 123-125
Authors:
SLEDGE GW
ROBERT N
SPARANO JA
COGLEIGH M
GOLDSTEIN LJ
NEUBERG D
ROWINSKY E
BAUGHMAN C
MCCASKILLSTEVENS W
Citation: Gw. Sledge et al., EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDIES OF PACLITAXEL AND DOXORUBICIN IN ADVANCED BREAST-CANCER, Seminars in oncology, 22(3), 1995, pp. 105-108
Authors:
FIFE RS
SLEDGE GW
Citation: Rs. Fife et Gw. Sledge, EFFECTS OF DOXYCYCLINE ON IN-VITRO GROWTH, MIGRATION, AND GELATINASE ACTIVITY OF BREAST-CARCINOMA CELLS, The Journal of laboratory and clinical medicine, 125(3), 1995, pp. 407-411
Authors:
BROXMEYER HE
HAGUE NL
SLEDGE GW
RASMUSSEN H
GORDON MS
Citation: He. Broxmeyer et al., SUPPRESSION OF MARROW AND MOBILIZATION OF BLOOD MYELOID PROGENITORS IN-VIVO BY BB10010, A GENETICALLY-ENGINEERED VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN (MIP)-1-ALPHA, IN A PHASE-1 CLINICAL-TRIAL IN PATIENTS WITH RELAPSED REFRACTORY BREAST-CANCER/, Blood, 86(10), 1995, pp. 37-37